Ixabepilone in metastatic breast cancer: complement or alternative to taxanes?
Tan
Antoinette R
AR
The Cancer Institute of New Jersey, New Brunswick, New Jersey 08901, USA. tanan@umdnj.edu
Toppmeyer
Deborah L
DL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002986:Clinical Trials as Topic; D034261:Epothilones / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D043823:Taxoids / Q000008:administration & dosage*; D050257:Tubulin Modulators / Q000008:administration & dosage*
D034261:Epothilones; D043823:Taxoids; D050257:Tubulin Modulators; C430592:ixabepilone